Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary vascular disease
characterized by progressive pulmonary artery pressure elevation, increased pulmonary …

Pulmonary hypertension (PH) is a refractory and fatal disease characterized by excessive
pulmonary arterial cell remodeling. Uncontrolled proliferation and hypertrophy of pulmonary …

Pulmonary hypertension (PH) is an intractable, severe, and progressive cardiopulmonary
disease. Recent findings suggest that human umbilical cord mesenchymal stromal cells …

Background Pulmonary arterial hypertension (PAH) is a fatal disease caused by pulmonary
vascular remodeling, with a high incidence and mortality. At present, many clinical drugs for …

Background Pulmonary hypertension (PH) represents a progressive condition characterized
by the remodeling of pulmonary arteries, ultimately culminating in right heart failure and …

Pulmonary hypertension (PH) is a chronic pulmonary vascular disorder characterized by an
increase in pulmonary vascular resistance and pulmonary arterial pressure. The detailed …

Uncovering the risk factors of pulmonary hypertension and its mechanisms is crucial for the
prevention and treatment of the disease. In the current study, we showed that experimental …

Cardiopulmonary complications remain the major cause of mortality despite newer therapies
and improvements in the lifespan of patients with sickle cell disease (SCD). Inflammation …

Pulmonary arterial hypertension (PAH) is a chronic, progressive disease characterized by
an increase in blood pressure in the lungs' arteries. It can occur in a variety of species …

Background Pulmonary arterial hypertension (PAH) is a pathophysiological syndrome,
characterized by pulmonary vascular remodeling. Immunity and inflammation are …